Ovarian Cancer Clinical Trials

A listing of Ovarian Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Chandler Arizona 85224

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Phoenix Arizona 85016

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Phoenix Arizona 85027

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

View More ▼

UPDATED

Tucson Arizona 85711

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Tucson Arizona 85704

A Phase 3 clinical study for patients with Ovarian Cancer

Arkansas

UPDATED

Fayetteville Arkansas 72703

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Rogers Arkansas 72758

A Phase 3 clinical study for patients with Ovarian Cancer

California

NEW

The Stanford Center for Clinical and Translational Education and Research Recruiting
Palo Alto California 94304

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

UPDATED

Irvine California 92614

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

La Jolla California 92093

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Newport Beach California 92663

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Sacramento California 95817

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

San Francisco California 94143

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Santa Barbara California 93105

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Santa Monica California 90403

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Santa Monica California 90404

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Solvang California 93463

A Phase 3 clinical study for patients with Ovarian Cancer

Colorado

NEW

Parkview Research Center
Aurora Colorado 80045

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

UPDATED

Aurora Colorado 80012

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Boulder Colorado 80303

A Phase 3 clinical study for patients with Ovarian Cancer

UPDATED

Lakewood Colorado 80228

A Phase 3 clinical study for patients with Ovarian Cancer

Connecticut

NEW

Smillow Cancer Hospital at Yale University Cancer Center Recruiting
New Haven Connecticut 06519

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

Florida

NEW

Mount Sinai Medical Center Recruiting and Research Recruiting
Miami Beach Florida 33140

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

UPDATED

Miami Beach Florida 33140

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Sarasota Florida 34232

A clinical research study of BTP-114 for the treatment of Pancreatic Neoplasms, Ovarian Neoplasms, Breast Neoplasms or Prostatic Neoplasms

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Georgia

NEW

The Winship Cancer Institute, Emory University Recruiting and Research Recruiting
Atlanta Georgia 30322

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Illinois

UPDATED

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Indiana

NEW

Parkview Research Center
Fort Wayne Indiana 46845

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

UPDATED

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Iowa

UPDATED

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Kentucky

UPDATED

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Maryland

UPDATED

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Massachusetts

NEW

Research Center
Additional Locations Massachusetts

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

NEW

Dana Farber Cancer Institute Recruiting and Research Recruiting
Boston Massachusetts 02115

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

UPDATED

Boston Massachusetts MA 02114

A clinical research study of APR-246, Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD) for the treatment of Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Michigan

NEW

Barbara Ann Karmanos Cancer Institute Recruiting
Detroit Michigan 48201

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

UPDATED

Detroit Michigan 48201

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

UPDATED

Detroit Michigan 48202

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Minnesota

UPDATED

Minneapolis Minnesota 55407

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Missouri

UPDATED

St. Louis Missouri 63110

A clinical research study of BTP-114 for the treatment of Pancreatic Neoplasms, Ovarian Neoplasms, Breast Neoplasms or Prostatic Neoplasms

New York

NEW

Memorial Sloan Kettering Cancer Center Recruiting
New York New York 10065

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

NEW

Columbia University Medical Center Recruiting
New York New York 10032

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers